Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection ...
Source:
University of Pittsburgh Schools of the Health Sciences
Monday, November 2, 2009